A recent meta-analysis reported a significantly increased risk of multifocality, extrathyroidal invasion, local and distant lymph node metastases, recurrence, and decreased 10-year survival in papillary microcarcinomas carrying the BRAF V600E mutation [55] (Table 2). Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.